期刊文献+

适配体及其在生物医药和诊断分析方面的应用 被引量:2

Aptamers and their biological applications in bio-medicine and analytical diagnostics
原文传递
导出
摘要 近年来,适配体倍受关注。因其具备抗体所有优势的同时,还具有热稳定,低成本和应用广泛等特点,而被认为是抗体的理想代替品。本文全面系统地总结了适配体技术及其在生物医学领域的应用:适配体筛选技术;适配体在生物传感技术方面的应用;适配体在特异性识别靶细胞(尤其是癌细胞)方面的探讨;适配体在诊断治疗及医学方面的应用。综述了核酸适配体的获得途径,体外修饰以及在各领域的应用。综合核酸适配体的一系列应用,发现其在生物医学方面应用极其广泛,也最具前景。 Aptamers which are known as the ideal alternatives of antibodies,have attracted interest of many scientists in recent years because they not only have all the advantages of antibodies,but also possess unique merits,such as thermal stability,low cost and unlimited applications.In this article,the aptamer-based technology and its applications in bio-medicine were summarized as follows:aptamer-based screening technology;applications of aptamers in bio-sensor technology;applications of aptamers in specifically recognizing the target cells,especially cancer cells;application of aptamers in therapeutic and diagnostic medicine.In addition,comprehensive range of applications of aptamers showed that aptamers were widely applied in the biomedical field and had great potential for development.
出处 《药物分析杂志》 CAS CSCD 北大核心 2016年第3期369-376,共8页 Chinese Journal of Pharmaceutical Analysis
关键词 适配体 寡核苷酸 抗体替代品 SELEX 适配体筛选 靶细胞识别 适配体生物传感 药物适配体 aptamer oligonucleotides antibodies to substitute SELEX aptamer bolting target cell recognition aptamer bio-sensing drug aptamer
  • 相关文献

参考文献4

二级参考文献75

  • 1付玉荣,邱宗荫.SELEX技术及其应用研究进展[J].国外医学(病毒学分册),2005,12(3):70-72. 被引量:6
  • 2Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment RNA ligands to bacteriophagc T4 DNA polymeras [J]. Science, 1990,249(4968):505-510.
  • 3Ellington A D, Szostak J W. In vitro selection of RNA molecules that bind specific ligands[J]. Nature, 1990,346(6287):818-822.
  • 4Konopka K, Lee N S, Rossi J, et al. Rev-binding aptamer and CMV promoter a decoys to inhibit HIV replication[J]. Gene, 2000, 255(2):235-244.
  • 5Gal S W, Amontov S, Urvil P T, et al. Selection of a RNA aptamer that binds to human activated protein C and inhibits its protease function[J]. Eur J Biochem, 1998,252(3):553-562.
  • 6Herr J K, Smith J E, Medley C D, et al. Aptamer-conjugated nanoparticles for selective collection and detection of cancer cells [J]. Anal Chem, 2006,78:2918-2924.
  • 7Tang Z, Shangguan D, Wang K, et al. Selection of aptamers for molecular recognition and characterization of cancer cells [J]. Anal Chem, 2007,79:4900-4907.
  • 8Morris K N, Jensen K B, Julin C M, et al. High atinity ligands from in vitro selection: complex targets [J]. Proc Natl Acad Sci USA, 1998(95):2902-2907.
  • 9Blank M, Weinschenk T, Priemer M, et al. Systematic evolution of a DNA aptamer binding to rat brain tumor mierovessels.selective targeting of endothelial regulatory protein pigpen [J]. J Biol Chem, 2001,276(19): 16464-16468.
  • 10Hick B J, Marion C, Chang Y F, et al. Tenascin-C aptamers are genetated using turner cells and purified protein [J]. J Biol Chem, 2001,276(52):48644-48654.

共引文献30

同被引文献24

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部